Chief Scientific Officer and Director Genomics Technologies
OmniSeq Inc., Roswell Park Comprehensive Cancer Center
Jun 18, 2024
Flexible Capabilities to Enable Comprehensive Genomic Profiling
Presented at:
The Power of Comprehensive Genomic Profiling Testing
Speakers
-
Jeremy Wallentine, MD
Pathologist Intermountain Health -
Nikoletta Sidiropoulos, MD
Associate Professor & Director Molecular Pathology University of Vermont Larner College of Medicine -
Moderator: Sue Beruti, MD, MHA
Sr. Medical Director, Clinical Genomics Illumina
Abstract
Comprehensive Genomic profiling (CGP) is becoming standard of care in oncology. It allows clinicians to maximize clinical information from limited biopsy samples so that patients are matched with approved therapies or enrolled in relevant clinical trials.
In this workshop, our panel will describe the implementation of a CGP assay at their institutions. They will also discuss how flexible automation, sample batching, data analysis and reporting solutions are key to offer CGP testing so that data access and turn-around time can benefit patients.
Learn:
- Reasons to implement and value of a flexible future-proof DNA+RNA CGP assay.
- The impact of reflex CGP testing on testing decision trees and workflow consolidation.
- Value of sample management and genomic literacy for oncologists and molecular tumor boards.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...